V S Clinical Research And Hospitals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth -46.87%
- Profit Growth -1205.29%
- Ebitda -394.28%
- Net Worth -146.37%
- Total Assets -23.51%
About V S Clinical Research And Hospitals
V S Clinical Research And Hospitals Private Limited (VSCRAHPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 August 2015 (Nine years and five months 12 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Loga Sri and Rajavarshan Ramamoorthy serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900TN2015PTC101918
-
Company No.
101918
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Aug 2015
-
Date of AGM
27 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at V S Clinical Research And Hospitals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Loga Sri
|
Director | 09-Aug-2016 | Current |
|
Rajavarshan Ramamoorthy
|
Additional Director | 04-Mar-2021 | Current |
Financial Performance of V S Clinical Research And Hospitals.
V S Clinical Research And Hospitals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 46.87% decrease. The company also saw a substantial fall in profitability, with a 1205.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 146.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of V S Clinical Research And Hospitals?
In 2019, V S Clinical Research And Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Lifespan Diagnostic LlpLoga Sri is a mutual person
-
Hexcorn Industries Private Limited
Rajavarshan Ramamoorthy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at V S Clinical Research And Hospitals?
Unlock and access historical data on people associated with V S Clinical Research And Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of V S Clinical Research And Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped V S Clinical Research And Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
